148 filings
Page 4 of 8
PRE 14A
gf0glea
15 Dec 22
Preliminary proxy
5:01pm
8-K
4hnmwob1miotwkh5
8 Dec 22
Entry into a Material Definitive Agreement
4:05pm
424B5
wepb9k0e
18 Nov 22
Prospectus supplement for primary offering
5:16pm
8-K
f33juan4 tfyqaod7slo
18 Nov 22
TFF Pharmaceuticals Prices $10.675 Million Offering of Common Stock and Warrants
5:15pm
424B5
w4nixdc6l2s337
17 Nov 22
Prospectus supplement for primary offering
5:01pm
8-K
987kez iktnni
14 Nov 22
TFF Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update
12:00am
8-K
mwal1s zg
8 Nov 22
Submission of Matters to a Vote of Security Holders
5:06pm
DEFA14A
vtu5ev
6 Oct 22
Additional proxy soliciting materials
5:29pm
8-K
8bcrq6k06yeww3 8m
30 Sep 22
Departure of Directors or Certain Officers
5:21pm
8-K
5ooslftm didoyi5
11 Aug 22
TFF Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update
4:07pm
8-K
ijgmx d3qfaroz3en3j
10 Jun 22
Entry into a Material Definitive Agreement
4:35pm
424B5
978tsufb5o5ald7zf
10 Jun 22
Prospectus supplement for primary offering
4:30pm
8-K
pnd41xigeqp
11 May 22
TFF Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update
4:01pm
8-K
8z01qfjby6n1bt
24 Mar 22
TFF Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
4:02pm
S-8
vxjwlgr12 a3pbg923r
27 Dec 21
Registration of securities for employees
4:06pm